Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 15q Overgrowth Syndrome
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 15q Overgrowth Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
15q Overgrowth Syndrome
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
15q Overgrowth Syndrome
0-0
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
15q Overgrowth Syndrome
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
15q Overgrowth Syndrome
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
15q Overgrowth Syndrome
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
15q Overgrowth Syndrome
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
15q Overgrowth Syndrome
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 15q-overgrowth-syndrome-C4749920 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 15q Overgrowth Syndrome | Discriminating power |
|---|---|---|---|
| Growth pattern | Overgrowth is not established from the supplied description. | The name suggests overgrowth, but this is not confirmed by source data. | Moderate |
| Development | Developmental delay and intellectual disability may occur. | Developmental effects are not established in the supplied data. | Moderate |
| Facial appearance | Distinctive facial features may be present. | Characteristic facial findings are not established here. | Low |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Chromosomal microarray shows a 21q22.11–q22.12 deletion
A confirmed deletion supports this specific diagnosis.
High
Congenital developmental delay with supportive genetic findings
This matches the limited source description.
Moderate
Need for developmental support and monitoring
Management is described as supportive rather than disease-specific.
Moderate
Choose 15q Overgrowth Syndrome when
Genetic testing implicates a 15q overgrowth-associated change
The diagnosis should rest on laboratory confirmation, not the name alone.
Moderate
Clinically suspected overgrowth syndrome
The supplied record gives no definitive clinical criteria.
Low
Alternative congenital genetic diagnosis is being considered
Sparse data mean clinician review is required before selection.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 15q Overgrowth Syndrome | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a deletion at 21q22.11–q22.12. | Expected 15q result is not established here. | A reported variant needs genetics review and clinical correlation. |
| Developmental assessment | May document delay or intellectual disability. | Expected findings are not established. | Assessment supports care planning but does not alone diagnose either condition. |
| Growth measurements | No specific growth pattern is established. | Overgrowth may be relevant but is unconfirmed. | Serial measurements require clinician interpretation. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Long-term outcome is not established; developmental support and monitoring are central.
- Factors
- Extent of developmental needs and associated medical findings may influence course.
15q Overgrowth Syndrome
- Outcome
- Outcome is not established from the supplied data.
- Factors
- Specific prognostic factors are unavailable.
Time frame: Both are described as chronic congenital conditions; exact timelines are not established.
Genetic confirmation, individual clinical findings, and access to supportive care.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning needs | Intellectual disability may require educational support. Learning complications are not established. Needs should be assessed individually. |
| Medical complexity | Described as severe and requiring monitoring. Listed as moderate, but complications are unspecified. Severity labels do not establish exact risks. |
| Associated anomalies | Beyond facial and developmental features, anomalies are not specified. Associated anomalies are not established. Screening should follow specialist advice. |
Patient education highlights
- HighGenetic confirmation
Ask whether testing specifically confirms the suspected chromosomal condition.
- HighSupportive care
Developmental, educational, and medical follow-up may be needed.
- MediumUncertainty
Limited source data, especially for 15q overgrowth syndrome, mean some comparisons are not established.